化学
溶解度
组合化学
等温滴定量热法
核磁共振波谱
三元运算
滴定法
酰胺
立体化学
环糊精
计算化学
合理设计
人口
水溶液
三元络合物
药物设计
亲缘关系
增溶
药品
赋形剂
蛋白质水解
光谱学
蛋白质折叠
蛋白质结构
折叠(DSP实现)
药物发现
圆二色性
生物物理学
合作性
同种类的
生物制药
作者
Matthew N. O’Brien Laramy,José G. Napolitano,Yuhui Zhou,David J. Russell,Sarah Robinson,Gennady Khirich,Alberto Gobbi
标识
DOI:10.1021/acs.molpharmaceut.5c01600
摘要
Bivalent protein degraders, or proteolysis targeting chimeras (PROTACs), are an emerging therapeutic modality that can be used to drug challenging targets and drive differentiated pharmacology. However, the atypical physicochemical and structural properties of PROTACs can contribute to poor biopharmaceutical properties (e.g., solubility), and complicate drug research and development. To date, there are limited publications on modality-specific formulation strategies to mitigate these liabilities. Herein, we use multiple NMR spectroscopy techniques, isothermal titration calorimetry, and quantitative solubility measurements to study solubilization of a VHL-based PROTAC for SMARCA2, A515. In aqueous solution without solubilizing excipients, we found that A515 exists in two distinct and measurable populations that differ in the rotation of the amide group─a trans -proline rotational isomer that comprises a set of relatively open conformations with larger hydrodynamic size, and a cis -proline rotational isomer with relatively condensed conformations with smaller hydrodynamic size. Upon addition of the solubilizing excipient 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) to A515, we show that the efficiency of ternary host–guest complexation (i.e., the mechanism of solubilization) in each population is distinct and modulated by conformation (i.e., the accessibility of the terminal regions of A515 that are involved in complexation). These observations highlight the unreported and important role of stereochemistry and conformation in the rational formulation design for PROTACs (including solubility enhancement), and suggest specific considerations for VHL-based PROTACs.
科研通智能强力驱动
Strongly Powered by AbleSci AI